How cancer patients get fake cancer information: From TV to YouTube, a qualitative study focusing on fenbendazole scandle (2022)

Peer-Reviewed Study · Kim, Oh, Shin, Jun · 2022

Kim et al., 2022: Korean focus-group study with 21 lung cancer patients about how they encountered fenbendazole claims during the 2020 'fenbendazole scandal'; most held a negative view of such complementary-medicine information and wanted it verified.

We conducted a focus group interview with 21 lung cancer patients who were informed about fenbendazole based on a semi-structured questionnaire with three categories

Abstract

Kim et al., 2022: Korean focus-group study with 21 lung cancer patients about how they encountered fenbendazole claims during the 2020 'fenbendazole scandal'; most held a negative view of such complementary-medicine information and wanted it verified. Study type: qualitative focus-group study, n=21 lung cancer patients (13 men, 8 women, aged 50+, stages I, III and IV, seven in each stage), South Korea, data on acquisition channels and perception. No drug was administered; dose/schedule not applicable. Declared conflicts: 'The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.' Funder: not captured in the record. Comparator: none. Finding at full strength: participants first met the false information through TV, then searched YouTube; they had only fragmented information; most were negative toward it. Study type: other.